Seventy-two patients with Rh erythroblastosis were treated with promethazine hydrochloride (P-HCl) during a seven-year period. Compared to the pregnancy outcome of the immediately preceding pregnancies, we have found a significant decrease in perinatal mortality and exchange transfusions. No significant toxicity from P-HCl treatment has been noted, and none of these patients developed preeclampsia.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
promethazine hydrochloride
8
treatment erythroblastosis
4
erythroblastosis promethazine
4
hydrochloride seventy-two
4
seventy-two patients
4
patients erythroblastosis
4
erythroblastosis treated
4
treated promethazine
4
hydrochloride p-hcl
4
p-hcl seven-year
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!